Search Results - "Liron, Tamar"
-
1
Mechanism and Prevention of Titanium Particle-Induced Inflammation and Osteolysis
Published in Frontiers in immunology (18-12-2018)“…The worldwide number of dental implants and orthopedic prostheses is steadily increasing. Orthopedic implant loosening, in the absence of infection, is mostly…”
Get full text
Journal Article -
2
Enhancer methylation dynamics contribute to cancer plasticity and patient mortality
Published in Genome research (01-05-2016)“…During development, enhancers play pivotal roles in regulating gene expression programs; however, their involvement in cancer progression has not been fully…”
Get full text
Journal Article -
3
The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Non-Melanoma Skin Cancer
Published in International journal of molecular sciences (24-04-2023)“…Five million non-melanoma skin cancers occur globally each year, and it is one of the most common malignant cancers. The dysregulation of the endocannabinoid…”
Get full text
Journal Article -
4
The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Colon Cancer: A Study in Mice and Humans
Published in International journal of molecular sciences (01-02-2023)“…The endocannabinoid system, particularly cannabinoid receptor 2 (CB2 in mice and CNR2 in humans), has controversial pathophysiological implications in colon…”
Get full text
Journal Article -
5
Bone loss in C57BL/6J‐OlaHsd mice, a substrain of C57BL/6J carrying mutated alpha‐synuclein and multimerin‐1 genes
Published in Journal of cellular physiology (01-01-2018)“…The inbred mouse strain C57BL/6 is commonly used for the generation of transgenic mouse and is a well established strain in bone research. Different vendors…”
Get full text
Journal Article -
6
The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice
Published in International journal of molecular sciences (21-12-2021)“…The two erythropoietin (EPO) receptor forms mediate different cellular responses to erythropoietin. While hematopoiesis is mediated via the homodimeric EPO…”
Get full text
Journal Article -
7
Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible
Published in International journal of molecular sciences (27-05-2020)“…Recent studies have demonstrated that erythropoietin (EPO) treatment in mice results in trabecular bone loss. Here, we investigated the dose-response…”
Get full text
Journal Article -
8
Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
Published in International journal of molecular sciences (01-10-2022)“…Erythropoietin (EPO) is a pleiotropic cytokine that classically drives erythropoiesis but can also induce bone loss by decreasing bone formation and increasing…”
Get full text
Journal Article -
9
Therapeutic Potential of Vasoactive Intestinal Peptide and its Derivative Stearyl-Norleucine-VIP in Inflammation-Induced Osteolysis
Published in Frontiers in pharmacology (05-05-2021)“…The common use of dental and orthopedic implants calls for special attention to the immune response leading to peri-prosthetic bone loss and implant failure…”
Get full text
Journal Article -
10
Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in Mice
Published in Frontiers in immunology (19-10-2020)“…Immunotherapy with anti-CD20-specific antibodies (rituximab), has become the standard of care for B cell lymphoproliferative disorders and many autoimmune…”
Get full text
Journal Article -
11
The non-erythropoietic analogue cibinetide inhibits osteoclastogenesis in vitro and increases bone density in mice
Published in Bone Reports (01-10-2020)Get full text
Journal Article -
12
Scaling of titanium implants entrains inflammation-induced osteolysis
Published in Scientific reports (06-01-2017)“…With millions of new dental and orthopedic implants inserted annually, periprosthetic osteolysis becomes a major concern. In dentistry, peri-implantitis…”
Get full text
Journal Article -
13
Isozyme-Specific Abnormalities of PKC in Thyroid Cancer: Evidence for Post-Transcriptional Changes in PKC Epsilon
Published in The journal of clinical endocrinology and metabolism (01-05-2002)“…PKC isozymes are the major binding proteins for tumor-promoting phorbol esters, and PKC activity is abnormal in a number of different human cancers. Less is…”
Get full text
Journal Article -
14
Erythropoietin directly stimulates osteoclast precursors and induces bone loss
Published in The FASEB journal (01-05-2015)“…ABSTRACT Erythropoietin (EPO) primarily regulates red blood cell formation, and EPO serum levels are increased on hypoxic stress (e.g., anemia and altitude)…”
Get full text
Journal Article -
15
Statins Enhance Rotator Cuff Healing by Stimulating the COX2/PGE2/EP4 Pathway: An In Vivo and In Vitro Study
Published in The American journal of sports medicine (01-12-2014)“…Background: Statins are lipid-lowering drugs with many beneficial pleiotropic effects. Cyclooxygenase (COX2) selective inhibitors that are commonly prescribed…”
Get full text
Journal Article -
16
Hormone‐Independent Sexual Dimorphism in the Regulation of Bone Resorption by Krox20
Published in Journal of bone and mineral research (01-12-2019)“…ABSTRACT Krox20/EGR2 is a zinc finger transcription factor, implicated in the development of the hindbrain, nerve myelination, and tumor suppression. In…”
Get full text
Journal Article -
17
The Non-Erythropoietic EPO Analogue (Cibinetide) Preserves Bone Mass in Mice
Published in Blood (23-11-2021)“…Background and aims: Erythropoietin (EPO) is a pleiotropic cytokine, which besides its classical role in driving erythropoiesis, displays tissue protective and…”
Get full text
Journal Article -
18
Anti-CD20-Mediated B Cell Depletion Is Associated with Reduced Osteoclastogenic Signals and Bone Mass Preservation: Clinical Observation in Patients with Follicular Lymphoma Supplemented By Animal Studies in a Murine Model
Published in Blood (05-11-2020)“…Background and aims: Immunotherapy with anti-CD20-specific antibodies (e.g. rituximab), has become the standard of care for B cell lymphoproliferative…”
Get full text
Journal Article -
19
Erythropoietin (EPO) Regulates Bone Mass Via EPO Receptors on Myeloid and Lymphocytic Cells
Published in Blood (29-11-2018)“…Background and aims: Erythropoietin (EPO) is the key regulator of red blood cell production. In response to hypoxia, EPO levels can increase 1000-fold and…”
Get full text
Journal Article -
20
Erythropoietin receptor in B cells plays a role in bone remodeling in mice
Published in Theranostics (01-01-2020)“…Erythropoietin (EPO) is a key regulator of erythropoiesis. However, EPO receptors (EPO-Rs) are also expressed on non-erythroid cell types, including myeloid…”
Get full text
Journal Article